| Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and … E Cędrowska, M Pruszyński, W Gawęda, M Żuk, P Krysiński, ... Molecules 25 (5), 1025, 2020 | 91 | 2020 |
| A novel metal-based imaging probe for targeted dual-modality SPECT/MR imaging of angiogenesis C Tsoukalas, D Psimadas, GA Kastis, V Koutoulidis, AL Harris, ... Frontiers in chemistry 6, 224, 2018 | 43 | 2018 |
| Gallium‐68 Labeled Iron Oxide Nanoparticles Coated with 2, 3‐Dicarboxypropane‐1, 1‐diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof‐of‐Concept Study MA Karageorgou, S Vranješ-Djurić, M Radović, A Lyberopoulou, B Antić, ... Contrast Media & Molecular Imaging 2017 (1), 6951240, 2017 | 40 | 2017 |
| Anticancer and biochemical effects of Viscum album L. protein extracts on HeLa cells S Mavrikou, V Tsekouras, MA Karageorgou, G Moschopoulou, S Kintzios Plant Cell, Tissue and Organ Culture (PCTOC) 140, 369-378, 2020 | 21 | 2020 |
| Radiolabeled iron oxide nanoparticles as dual modality contrast agents in SPECT/MRI and PET/MRI MA Karageorgou, P Bouziotis, E Stiliaris, D Stamopoulos Nanomaterials 13 (3), 503, 2023 | 18 | 2023 |
| Detection of superoxide alterations induced by 5-fluorouracil on HeLa cells with a cell-based biosensor S Mavrikou, V Tsekouras, MA Karageorgou, G Moschopoulou, S Kintzios Biosensors 9 (4), 126, 2019 | 18 | 2019 |
| 90Y-CA/SPIONs for dual magnetic hyperthermia-radionuclide nanobrachytherapy of solid tumours A Vukadinović, Z Milanović, M Ognjanović, D Janković, M Radović, ... Nanotechnology 33 (40), 405102, 2022 | 10 | 2022 |
| Hemocompatibility of gallium-68 labeled iron oxide nanoparticles coated with 2, 3-dicarboxypropane-1, 1-diphosphonic acid MA Karageorgou, P Bouziotis, S Vranješ-Djurić, D Stamopoulos Materials Science and Engineering: C 115, 111121, 2020 | 10 | 2020 |
| Drug delivery nanosystems: From bioinspiration and biomimetics to clinical applications N Pippa, C Demetzos, S Pispas CRC Press, 2019 | 9 | 2019 |
| 99mTc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera … MA Karageorgou, AN Rapsomanikis, M Mirković, S Vranješ-Ðurić, ... Nanomaterials 12 (15), 2728, 2022 | 7 | 2022 |
| Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles MA Karageorgou, D Stamopoulos Scientific Reports 11 (1), 9753, 2021 | 7 | 2021 |
| Ferroelectric/Piezoelectric Materials in Energy Harvesting: Physical Properties and Current Status of Applications MA Karageorgou, K Tsakmakidis, D Stamopoulos Crystals 14 (9), 806, 2024 | | 2024 |
| Gamma-Camera Direct Imaging of the Plasma and On/Intra Cellular Distribution of the 99mTc-DPD-Fe3O4 Dual-Modality Contrast Agent in Peripheral Human … MA Karageorgou, A Apostolopoulou, ME Tomazinaki, D Stanković, ... Materials 17 (2), 335, 2024 | | 2024 |
| Radiolabeled magnetic nanoparticles for dual-modality disease imaging MA Karageorgou Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Σχολή Θετικών Επιστημών …, 2022 | | 2022 |
| Radiolabeled Nanoparticles as Diagnostic and Therapeutic Agents of Cancer C Tsoukalas, MA Karageorgou, P Bouziotis Drug Delivery Nanosystems, 291-337, 2019 | | 2019 |
| Chelator-free Radiolabeling of Iron Oxide Nanoparticles with Ga-68 For Dual-Modality PET/MR Imaging M Karageorgou, J Gallo, C Tsoukalas, S Xanthopoulos, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 44, S309-S310, 2017 | | 2017 |
| Contribution to the determination of locomotive impairments and associated fall risk level in the ageing community Μ Καραγεώργου | | 2012 |
| 68Ga-DPD-Fe3O4 as a dual-modality contrast agent: magnetic resonance imaging on mice MA Karageorgou, P Bouziotis, D Stamopoulos | | |
| 68Ga-DPD-Fe3O4 as a dual-modality contrast agent: biodistribution study on mice and biocompatibility with peripheral human blood cells MA Karageorgou, P Bouziotis, D Stamopoulos | | |
